Antibodies to Ganglioside Complexes in Guillain-Barré Syndrome: Clinical Correlates, Fine Specificity and Complement Activation (original) (raw)
Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome
Nina M van Sorge
Autoimmunity Reviews, 2004
View PDFchevron_right
Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
Joe Conner
Journal of Clinical Investigation, 1999
View PDFchevron_right
Gangliosides and bacterial toxins in Guillain-Barré syndrome
Hugh Willison
Journal of Neuroimmunology, 1993
View PDFchevron_right
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review
Toshio Ariga
Glycobiology, 2009
View PDFchevron_right
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome
Denis Brochu
Journal of Clinical Investigation, 2004
View PDFchevron_right
Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barre Syndrome and Related Diseases
Toshio Ariga
Infection and Immunity, 2006
View PDFchevron_right
Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndrome
Janbernd Kirschner
Archives of Disease in Childhood, 2007
View PDFchevron_right
Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay
Carla D'Avino
Journal of the Neurological Sciences, 2002
View PDFchevron_right
Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies
Guido Cavaletti
Journal of The Neurological Sciences, 1999
View PDFchevron_right
Anti‐ganglioside antibodies and elevated CSF IgG levels in Guillain‐Barré syndrome
A. Amantini
European Journal of Neurology, 2006
View PDFchevron_right
Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain–Barré syndrome
Nina M van Sorge
Journal of Neuroimmunology, 2007
View PDFchevron_right
Mechanisms of Action of Anti‐GM1and Anti‐GQ1bGanglioside Antibodies in Guillain‐Barré Syndrome
Hugh Willison
The Journal of Infectious Diseases, 1997
View PDFchevron_right
Preceding infections and anti-ganglioside antibodies in patients with Guillain?Barr� syndrome: a single centre prospective case-control study
Chandra M Pandey
Clin Microbiol Infect, 2007
View PDFchevron_right
Assessment of Anti-Ganglioside Antibodies in Patients Diagnosed With Guillain Barre Syndrome
Hikmat Ullah
Pakistan Armed Forces Medical Journal, 2022
View PDFchevron_right
Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan
Michiaki Koga, Satoshi Kuwabara
Annals of Neurology, 2000
View PDFchevron_right
T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1
Pamela McCombe
Journal of Clinical Neuroscience, 2010
View PDFchevron_right
Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome
Pamela McCombe
Journal of Clinical Neuroscience, 2005
View PDFchevron_right
Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure
Albert Lastovica
Infection and immunity, 1994
View PDFchevron_right
Structure ofCampylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients
Hugh Willison
Infection and Immunity, 2002
View PDFchevron_right
Antibodies to single glycolipids and glycolipid complexes in Guillain-Barre syndrome subtypes
Satoshi Kuwabara
Neurology, 2014
View PDFchevron_right
Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study
Bum Suh, Nam-hee Kim, Young-eun Park, Tai-seung Nam, Seong-hae Jeong
Journal of clinical neurology (Seoul, Korea), 2014
View PDFchevron_right
Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome
Mojtaba Barzegar, M. Hashemilar, Reza Badalzadeh
Iranian journal of …, 2010
View PDFchevron_right
Guillain-Barré Syndrome: What We Know and Where We Can Improve
Clara Reynolds
2018
View PDFchevron_right
Experimental Guillain-Barre syndrome induced by immunization with gangliosides: Keyhole limpet hemocyanin is required for disease triggering
Samanta Funes
Biochimica et biophysica acta, 2017
View PDFchevron_right
Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies
Hugh Willison
PLoS ONE, 2012
View PDFchevron_right
Electrophysiological assessment of Guillain-Barré syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type
Makoto Samukawa
Journal of Neuroimmunology, 2016
View PDFchevron_right
Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals
Hugh Willison
Clinical and Experimental Neuroimmunology, 2011
View PDFchevron_right
Axonal Guillain-Barré syndrome: concepts and controversies
Satoshi Kuwabara
The Lancet Neurology, 2013
View PDFchevron_right
Anti-GM1 IgG antibodies and campylobacter bacteria in Guillain-Barré syndrome: Evidence of molecular mimicry
Peter Oomes
1995
View PDFchevron_right
The spectrum of immune responses toCampylobacter jejuni and glycoconjugates in Guillain-Barr� syndrome and in other neuroimmunological disorders
Hans-peter Hartung
Annals of Neurology, 1993
View PDFchevron_right
Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies
Eduardo Nobile-orazio
Journal of the Neurological Sciences, 1992
View PDFchevron_right
Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barre syndrome
Michiaki Koga
Journal of Neurology, Neurosurgery & Psychiatry, 2001
View PDFchevron_right
Guillain-Barré Syndrome: Modern Theories of Etiology
Pamela McCombe
Current Allergy and Asthma Reports, 2011
View PDFchevron_right
Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides in Campylobacter jejuni Strains Associated with Guillain-BarreSyndrome
Joe Conner
View PDFchevron_right